Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04439032 · ClinicalTrials.gov registry record
Artoss Prospective Spine Registry Outcomes
A clinical trial of Spinal Fusion, sponsored by Artoss.
- Active
- Registry status
- 330
- Enrollment target
- 6
- Study locations
NCT04439032: Active study of Spinal Fusion, sponsored by Artoss.
NCT04439032 is a study of Spinal Fusion that is active but no longer recruiting, run by Artoss. The registered enrollment target is 330 participants, below the 466-participant average among 19 other Spinal Fusion trials with a reported enrollment target (29% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04439032, a study of Spinal Fusion, is active but no longer recruiting, sponsored by Artoss.
- ACTIVE NOT RECRUITING
- Registry status
- 330 participants
- Enrollment target
- 6
- Study locations
Study Summary
This prospective registry was designed as an observational study to ascertain how commercially available NanoBone Bone Graft is being used by surgeons performing spinal fusion as well as determining relevant patient outcomes.
Primary Outcome
Evidence of bony bridging between vertebral endplates and/or transverse processes of bone grafted vertebrae or absence of motion between vertebral bodies or both.
Conditions Studied
Interventions
- OTHER NanoBone Bone Graft Substitute
Study Locations (6)
Arizona
- OrthoArizona - Chandler
- Sonoran Spine - Tempe
California
- SENTA Clinic - San Diego
Connecticut
- Hartford Health Care - Hartford
Maryland
- OrthoBethesda - Bethesda
Mississippi
- Sam Shamsnia MD Neurosurgery - Biloxi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2020-08-03 |
| Est. Completion | 2025-06-30 |
What the registry record for NCT04439032 still lists
NCT04439032 is an observational study that tracks outcomes without assigning an intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 466-participant average among 19 other Spinal Fusion trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Spinal Fusion appearing as the primary indexed condition, and to 1 intervention - of which NanoBone Bone Graft Substitute is the first listed.
NCT04439032 lists 6 locations in 5 states (Arizona, California, Connecticut).
Frequently Asked Questions
What is clinical trial NCT04439032 about?
NCT04439032 is a clinical study titled "Artoss Prospective Spine Registry Outcomes". This prospective registry was designed as an observational study to ascertain how commercially available NanoBone Bone Graft is being used by surgeons performing spinal fusion as well as determining relevant patient outcomes.
What is the current status of trial NCT04439032?
This trial is currently active not recruiting. The enrollment target is 330 participants. The study started on 2020-08-03. Estimated completion is 2025-06-30.
What conditions does trial NCT04439032 study?
This clinical trial studies the following conditions: Spinal Fusion.
What interventions are being tested in trial NCT04439032?
The interventions under investigation include: NanoBone Bone Graft Substitute (OTHER).
Who is sponsoring clinical trial NCT04439032?
This trial is sponsored by Artoss, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04439032 being conducted?
This trial has 6 study locations across Arizona, California, Connecticut, Maryland, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04439032's enrollment target sits among peer trials
330 4th of 19 higher than 16 of 19 other Spinal Fusion trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Fusion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Pulse-Width Modulation
RECRUITING · NA
-
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
RECRUITING · Phase 2
-
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
RECRUITING
-
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
RECRUITING · NA
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI